Zdrowie i gospodarka · 16/02/2018
FDA Announces Draft Guidance for ALS Drug Development
The FDA has released a draft guidance to help pharmaceutical companies develop drugs for treating amyotrophic lateral sclerosis (ALS), a progressive neurological disease characterized by muscle weakness and shortened survival.